View Older Stories View More Recent Stories

May 9, 2022 07:00AM Amicus Therapeutics Announces First Quarter 2022 Financial Results
May 4, 2022 07:00AM Amicus Therapeutics to Present at the Bank of America 2022 Healthcare Conference
Apr 26, 2022 07:00AM Amicus Therapeutics to Announce First Quarter 2022 Financial Results on May 9, 2022
Apr 19, 2022 07:02AM Amicus Therapeutics (FOLD) Issues New US Composition of Matter Patent for Galafold
Apr 19, 2022 07:00AM Amicus Announces Issuance of New U.S. Composition of Matter Patent for Galafold® (migalastat), Strengthening Patent Protection Through 2038
Mar 16, 2022 07:01AM Amicus Therapeutics (FOLD) Announces Positive Long-Term Data from Phase 1/2 Study of AT-GAA in Pompe Disease at the 2022 MDA Clinical & Scientific Conference
Mar 16, 2022 07:00AM Amicus Therapeutics Announces Positive Long-Term Data from Phase 1/2 Study of AT-GAA in Pompe Disease at the 2022 MDA Clinical & Scientific Conference
Mar 10, 2022 07:00AM Amicus Therapeutics Announces Presentation and Posters at the 2022 MDA Clinical & Scientific Conference
Mar 1, 2022 07:00AM Amicus Therapeutics to Present at the Cowen 42nd Annual Health Care Conference
Feb 24, 2022 07:00AM Amicus Therapeutics Announces Full-Year 2021 Financial Results and Corporate Updates
Feb 10, 2022 07:00AM Amicus Therapeutics to Announce Full-Year 2021 Financial Results on February 24, 2022
Feb 7, 2022 07:00AM Amicus Therapeutics Announces Presentations and Posters at the 18th Annual WORLDSymposium™ 2022
Jan 10, 2022 07:15AM Amicus Therapeutics (FOLD) Reports Preliminary 2021 Revenue, Provides 2022 Strategic Outlook and Revenue Guidance
Jan 10, 2022 07:00AM Amicus Therapeutics Reports Preliminary 2021 Revenue and Provides 2022 Strategic Outlook and Revenue Guidance
Jan 5, 2022 07:00AM Amicus Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference
Dec 3, 2021 07:07AM Amicus Therapeutics (FOLD) Announces EMA Validates Amicus Therapeutics Marketing Authorization Applications for AT-GAA for the Treatment of Pompe Disease
Dec 3, 2021 07:00AM European Medicines Agency Validates Amicus Therapeutics Marketing Authorization Applications for AT-GAA for the Treatment of Pompe Disease
Nov 24, 2021 07:00AM Amicus Therapeutics to Present at the 4th Annual Evercore ISI HealthCONx Virtual Conference
Nov 22, 2021 07:00AM Amicus Therapeutics Announces Presentations at the 14th International Congress of Inborn Errors of Metabolism
Nov 18, 2021 07:01AM Amicus Therapeutics (FOLD) Announces Publication of Phase 3 PROPEL Study Results of AT-GAA in Late-Onset Pompe Disease
Nov 18, 2021 07:00AM The Lancet Neurology Publishes Pivotal Phase 3 PROPEL Study Results of AT-GAA in Late-Onset Pompe Disease
Nov 11, 2021 07:00AM Amicus Therapeutics to Present at the Stifel 2021 Virtual Healthcare Conference
Nov 9, 2021 07:00AM Amicus Therapeutics Announces Third Quarter 2021 Financial Results and Corporate Updates
Nov 3, 2021 07:00AM Amicus Therapeutics to Announce Third Quarter 2021 Financial Results on November 9, 2021
Sep 29, 2021 06:35AM Amicus Therapeutics (FOLD) Announces U.S. FDA Accepts Filings for its AT-GAA for the Treatment of Pompe Disease
Sep 29, 2021 06:32AM Amicus Therapeutics (FOLD) and ARYA Sciences Acquisition Corp IV (ARYD) Announce Formation of a Next-Generation Genetic Medicine Company: “Caritas Therapeutics”
Sep 29, 2021 06:30AM U.S. FDA Accepts Filings for Amicus’ AT-GAA for the Treatment of Pompe Disease
Sep 29, 2021 06:30AM Amicus Therapeutics and ARYA Sciences Acquisition Corp IV Announce Formation of a Next-Generation Genetic Medicine Company: “Caritas Therapeutics”
Sep 20, 2021 07:00AM Amicus Therapeutics Announces Presentations at the 26th International Annual Congress of the World Muscle Society
Sep 3, 2021 07:00AM Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2021
Aug 5, 2021 07:00AM Amicus Therapeutics Announces Second Quarter 2021 Financial Results and Corporate Updates
Aug 4, 2021 07:00AM Amicus Therapeutics to Present at the BTIG Virtual Biotechnology Conference
Aug 2, 2021 07:11AM Amicus Therapeutics (FOLD) Announces European Commission Approval of Galafold for Adolescents with Fabry Disease
Aug 2, 2021 07:00AM Amicus Therapeutics Announces European Commission Approval of Galafold® (migalastat) for Adolescents with Fabry Disease
Jul 27, 2021 07:00AM Amicus Therapeutics to Announce Second Quarter 2021 Financial Results on August 5, 2021
Jun 14, 2021 07:07AM Amicus Therapeutics (FOLD) Appoints Eiry W. Roberts, M.D. to its Board of Directors
Jun 14, 2021 07:00AM Amicus Therapeutics Appoints Eiry W. Roberts, M.D. to its Board of Directors
Jun 8, 2021 07:08AM Amicus Therapeutics (FOLD) Announces United Kingdom’s MHRA Grants Early Access to AT-GAA
Jun 8, 2021 07:00AM Amicus Therapeutics Announces United Kingdom’s MHRA Grants Early Access to AT-GAA
May 28, 2021 07:00AM Amicus Therapeutics to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference
May 21, 2021 07:00AM Amicus Therapeutics Announces Upcoming Presentations at the 16th International Congress on Neuromuscular Diseases
May 10, 2021 07:00AM Amicus Therapeutics Announces First Quarter 2021 Financial Results and Corporate Updates
May 7, 2021 07:00AM Amicus Therapeutics to Present at Upcoming Investor Conferences in May 2021
May 6, 2021 07:00AM Amicus Therapeutics Appoints Sébastien Martel as Senior Vice President of Strategy and Business Development
May 5, 2021 07:00AM Amicus Therapeutics Announces Upcoming Presentations at the American Society of Gene & Cell Therapy 24th Annual Meeting
May 3, 2021 07:05AM Amicus Therapeutics (FOLD) Announces Successful Pre-BLA Meeting with U.S. FDA for AT-GAA for the Treatment of Pompe Disease
May 3, 2021 07:00AM Amicus Therapeutics Announces Successful Pre-BLA Meeting with U.S. FDA for AT-GAA for the Treatment of Pompe Disease
Apr 28, 2021 07:00AM Amicus Therapeutics Recognized as a Great Place to Work® in Europe
Apr 26, 2021 07:00AM Amicus Therapeutics to Announce First Quarter 2021 Financial Results on May 10, 2021
Mar 15, 2021 07:00AM Amicus Therapeutics Announces Presentation and Posters at the 2021 MDA Clinical & Scientific Conference
View More Recent Stories View Older Stories